ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

NIH funds four centers to study breast cancer and the environment.

October 17, 2003

ICC Honors Inouye, Volunteers For Work With Minorities.

February 18, 2000

Zeneca Buys 50% Stake In Salick, Gets Managed Care Access

January 6, 1995